The implications of single protein detection are significant and may lay the foundation for improved medical therapeutics.
Just months after setting a record for detecting the smallest single virus in solution, researchers at the Polytechnic Institute of New York University (NYU-Poly) have announced a new breakthrough: They used a nano-enhanced version of their patented microcavity biosensor to detect a single cancer marker protein, which is one-sixth the size of the smallest virus, and even smaller molecules below the mass of all known markers. This achievement shatters the previous record, setting a new benchmark for the most sensitive limit of detection, and may significantly advance early disease diagnostics. Unlike current technology, which attaches a fluorescent molecule, or label, to the antigen to allow it to be seen, the new process detects the antigen without an interfering label.
Stephen Arnold, university professor of applied physics and member of the Othmer-Jacobs Department of Chemical and Biomolecular Engineering, published details of the achievement in Nano Letters, a publication of the American Chemical Society.
In 2012, Arnold and his team were able to detect in solution the smallest known RNA virus, MS2, with a mass of 6 attograms. Now, with experimental work by postdoctoral fellow Venkata Dantham and former student David Keng, two proteins have been detected: a human cancer marker protein called Thyroglobulin, with a mass of just 1 attogram, and the bovine form of a common plasma protein, serum albumin, with a far smaller mass of 0.11 attogram. “An attogram is a millionth of a millionth of a millionth of a gram,” said Arnold, “and we believe that our new limit of detection may be smaller than 0.01 attogram.”
This latest milestone builds on a technique pioneered by Arnold and collaborators from NYU-Poly and Fordham University. In 2012, the researchers set the first sizing record by treating a novel biosensor with plasmonic gold nano-receptors, enhancing the electric field of the sensor and allowing even the smallest shifts in resonant frequency to be detected. Their plan was to design a medical diagnostic device capable of identifying a single virus particle in a point-of-care setting, without the use of special assay preparations.
At the time, the notion of detecting a single protein—phenomenally smaller than a virus—was set forth as the ultimate goal.
“Proteins run the body,” explained Arnold. “When the immune system encounters virus, it pumps out huge quantities of antibody proteins, and all cancers generate protein markers. A test capable of detecting a single protein would be the most sensitive diagnostic test imaginable.”
To the surprise of the researchers, examination of their nanoreceptor under a transmission electron microscope revealed that its gold shell surface was covered with random bumps roughly the size of a protein. Computer mapping and simulations created by Stephen Holler, once Arnold’s student and now assistant professor of physics at Fordham University, showed that these irregularities generate their own highly reactive local sensitivity field extending out several nanometers, amplifying the capabilities of the sensor far beyond original predictions. “A virus is far too large to be aided in detection by this field,” Arnold said. “Proteins are just a few nanometers across—exactly the right size to register in this space.”
The implications of single protein detection are significant and may lay the foundation for improved medical therapeutics. Among other advances, Arnold and his colleagues posit that the ability to follow a signal in real time—to actually witness the detection of a single disease marker protein and track its movement—may yield new understanding of how proteins attach to antibodies.
The Latest Bing News on:
Cancer Marker Detection
- Liquid Biopsy Market 2021: Market Share, Size, Competition Landscape, Manufacturers Analysis and Future Opportunity Outlook - 2026on January 21, 2021 at 2:27 pm
This report by Future Market Insights (FMI) examines the 'Liquid Biopsy Market' for the period 2016-2026. The primary objective of the report is to offer updates and information related to market ...
- Trial targets metastatic prostate cancer by switching order of treatmentson January 21, 2021 at 8:09 am
Investigators at MUSC Hollings Cancer Center are conducting a clinical trial to determine whether changing the order in which certain treatments ...
- ANGLE liquid biopsy beats the gold standard when it comes to identifying cells that are indicative of cancer spreadon January 19, 2021 at 11:44 pm
The work was carried out by researchers at Western University and Lawson Health Research Institute, Ontario, Canada ...
- Angle PLC Announces Research Confirms High Performance of Parsortixon January 19, 2021 at 11:28 pm
PARSORTIX SYSTEM IS “IDEAL CTC PLATFORM FOR USE IN CLINICAL TRIALS AND CLINICAL PATIENT MANAGEMENT” Independent research confirms high performance of Parsortix® system in isolating CTCs for downstream ...
- This New Device Is Revolutionizing Breast Surgery at Fox Chase Cancer Centeron January 19, 2021 at 1:11 pm
The center is now using SmartClip Soft Tissue Marker, which provides 3D, GPS-like navigation to help surgeons extract tumors with more precision.
- Genetic Data, Medical Imaging Inform Prostate Cancer Risk Predictionon January 18, 2021 at 6:41 am
Combining genetic data and medical imaging could help improve risk prediction for prostate cancer progression.
- New tests may help improve the selection of men considering prostate cancer surveillanceon January 17, 2021 at 5:13 am
Sylvester Comprehensive Cancer Center researchers are looking at ways to combine imaging and biomarkers to predict prostate cancer progression more accurately.
- Day Three of Bionano’s Next-Generation Cytogenomics Symposium: Saphyr Provides Complete ...on January 15, 2021 at 1:02 am
Generation Cytogenomics Symposium featured six Saphyr users presenting their results and experiences using the Saphyr® system for optical genome mapping (OGM) to analyze solid tumor genomes. The ...
- Norfolk hospital is first to join new breast cancer trialon January 14, 2021 at 11:41 am
A Norfolk hospital has become the first to sign up for a ground-breaking breast cancer trial. Researchers at the Queen ...
- 14 New Monoclonal Anti-Cytokeratin Antibodies from AbboMaxon January 13, 2021 at 12:05 am
AbboMax adds over a dozen new anti-cytokeratin monoclonal antibodies to its inventory. Cytokeratins are proteins found in epithelium. A variety of cytokeratins can be used for subtyping various forms ...
The Latest Google Headlines on:
Cancer Marker Detection
The Latest Bing News on:
Single protein detection
- Progenity Reaches Two Million Test Milestoneon January 20, 2021 at 9:58 pm
(Nasdaq: PROG), a biotechnology company with an established track record of success in developing and commercializing molecular testing products, has reported the completion of two million diagnostic ...
- New COVID strain B117: What to know about highly contagious variant from United Kingdom that has spread to Massachusetts, other stateson January 18, 2021 at 5:51 am
The strain, which was first reported in September, is far more contagious, though there is no evidence yet suggesting it is any more deadly.
- E-cigarettes stress lungs, impair protein functionon January 17, 2021 at 9:00 pm
E-cigarette exposure stresses and inflames the lungs of rats, compromising important quality control proteins, according to new research.
- SARS-CoV-2 anti-N rigid monoclonal antibodies provide accurate early diagnosison January 17, 2021 at 8:56 pm
An interesting new preprint research paper that was posted on the bioRxiv* server recently describes the use of rigid monoclonal antibodies (mAbs) in contrast to flexible mAbs, and how this affects ...
- The Coronavirus Is Evolving Before Our Eyeson January 15, 2021 at 8:29 pm
All viruses are constantly evolving and changing, just as human populations are. When a virus is spreading as widely and rapidly as SARS-CoV-2, spinning through trillions of generations each minute, ...
- Society for Science Announces Top 300 Scholars in Science Talent Search Including Many Indian Americanson January 14, 2021 at 12:00 pm
Society for Science Jan. 7 announced the top 300 Scholars in the Regeneron Science Talent Search 2021, the nation’s oldest and most prestigious science and math competition for high school ...
- COVID Tester Uses Laser-Drilled, Coated Graphene Sensorson January 13, 2021 at 7:27 am
A Caltech research team built a standalone unit that could enable “on the spot” testing of the COVID virus and deliver results in approximately 10 minutes.
- Lantheus Holdings Announces Submission of Drug Master File for NM-01 in the U.S.on January 12, 2021 at 10:55 pm
Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), the parent company of Lantheus Medical Imaging, Inc. and Progenics Pharmaceuticals, Inc., and a global leader in the development, manufacture and ...
- How one pathogen evades the immune systemon January 12, 2021 at 6:17 am
An LMU research team led by Nicolai Siegel has uncovered a mechanism that enables the parasite that causes sleeping sickness in humans to escape the attention of the immune system. The finding may ...
- Freenome’s Multiomics Blood Test Shows Promising Results in Detecting Colorectal Advanced Adenomas in a Prospective, Multi-Center Clinical Studyon January 12, 2021 at 6:00 am
Freenome, a privately held biotechnology company that has pioneered a comprehensive multiomics platform for early cancer detection with a routine blood draw, today announced that it will be presenting ...